DE602004020584D1 - Diagnostische verwendung von scn2b für alzheimer erkrankung - Google Patents

Diagnostische verwendung von scn2b für alzheimer erkrankung

Info

Publication number
DE602004020584D1
DE602004020584D1 DE602004020584T DE602004020584T DE602004020584D1 DE 602004020584 D1 DE602004020584 D1 DE 602004020584D1 DE 602004020584 T DE602004020584 T DE 602004020584T DE 602004020584 T DE602004020584 T DE 602004020584T DE 602004020584 D1 DE602004020584 D1 DE 602004020584D1
Authority
DE
Germany
Prior art keywords
scn2b
alzheimer disease
diagnostic use
diagnostic
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004020584T
Other languages
English (en)
Inventor
Der Kammer Heinz Von
Johannes Pohlner
Jozef Hanes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evotec Neurosciences GmbH
Original Assignee
Evotec Neurosciences GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evotec Neurosciences GmbH filed Critical Evotec Neurosciences GmbH
Priority claimed from PCT/EP2004/000916 external-priority patent/WO2004070388A1/en
Publication of DE602004020584D1 publication Critical patent/DE602004020584D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602004020584T 2003-02-04 2004-02-02 Diagnostische verwendung von scn2b für alzheimer erkrankung Expired - Fee Related DE602004020584D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44466603P 2003-02-04 2003-02-04
PCT/EP2004/000916 WO2004070388A1 (en) 2003-02-04 2004-02-02 Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases

Publications (1)

Publication Number Publication Date
DE602004020584D1 true DE602004020584D1 (de) 2009-05-28

Family

ID=32852231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020584T Expired - Fee Related DE602004020584D1 (de) 2003-02-04 2004-02-02 Diagnostische verwendung von scn2b für alzheimer erkrankung

Country Status (3)

Country Link
JP (1) JP2006518199A (de)
AT (1) ATE428932T1 (de)
DE (1) DE602004020584D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021197100A (ja) * 2020-06-18 2021-12-27 国立研究開発法人産業技術総合研究所 情報処理システム、情報処理方法、同定方法及びプログラム

Also Published As

Publication number Publication date
ATE428932T1 (de) 2009-05-15
JP2006518199A (ja) 2006-08-10

Similar Documents

Publication Publication Date Title
DK1597282T3 (da) Antistofmolekyler, der har specificitet for human IL-1 beta
DE602005020209D1 (de) System zur Evaluierung von Herzstörungen
DE502004011497D1 (de) Chirurgisches Instrument
DE602005002836D1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
DE602006012262D1 (de) Behandlunsgsinstrument für ein Endoskop
DE602005018508D1 (de) Keine ads-b-daten verfügbar sind
DK2471483T4 (da) Kirurgisk planlægning
DE602006010132D1 (de) Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol
CY2013046I2 (el) Καινοτομος χρηση των αντισωματων αντι il-1bhta
DE602006016589D1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
DE60327236D1 (de) Medizinisches biopsieinstrument
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE602004027637D1 (de) Verwendung von cupredoxin-proteine für krebstherapie
DE102006001077A8 (de) Hochfrequenz-Behandlungsinstrument für ein Endoskop
DE602004030944D1 (de) Instrument für ein Endoskop
NO20035142D0 (no) N¶rhetsdetektor
DE60116365D1 (de) Radiopharmazeutika für die diagnose von alzheimer
ATE400206T1 (de) Ausziehführungsgarnitur für schubladen
DE602005020361D1 (de) Einzelfalten-vorrichtung für die fixierung von gewebe
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren
DE602004028071D1 (de) Halter - Anordnung für eine medizinische Naddle
DE602004000991D1 (de) Gleitstruktur für Klavierinstrument
DE502004005673D1 (de) Medizinisches Instrument
DE60313830D1 (de) Messfühlerartefaktreduzierung für Herzdiagnosegerät
FI20030778A0 (fi) Taudin määrittäminen tai ennustaminen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee